Viridium Pacific Group Ltd (CVE:VIR – Get Free Report) shares rose 5.6% on Wednesday. The company traded as high as C$0.41 and last traded at C$0.38. Approximately 26,500 shares were traded during trading, a decline of 71% from the average session volume of 92,632 shares. The stock had previously closed at C$0.36.
Viridium Pacific Group Stock Performance
The business’s 50 day moving average price is C$0.38 and its 200-day moving average price is C$0.38. The firm has a market capitalization of C$37.52 million and a PE ratio of -2.97.
Viridium Pacific Group Company Profile
Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.
See Also
- Five stocks we like better than Viridium Pacific Group
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
Receive News & Ratings for Viridium Pacific Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viridium Pacific Group and related companies with MarketBeat.com's FREE daily email newsletter.
